This article refers to:
Article title: Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study
Authors: Sham Mailankody, Meghan Salcedo, Elizabet Tavitian, Miranda Burge, Neha Korde, Hani Hassoun, Alexander Lesokhin, Oscar Lahoud, Eric Smith, Malin Hultcrantz, Carlyn Tan, Urvi Shah, Sean Devlin and Ola Landgren
Journal: Leukemia & Lymphoma
DOI: https://doi.org/10.1080/10428194.2022.2095626
The disclosure statement has been incorrectly updated in the proof.
The correct statement has been updated in the original version of the article.